Gongwin Biopharm Holdings Co., Ltd. (TPEX:6617)
Taiwan · Delayed Price · Currency is TWD 137.00
+9.00 (7.03%)
Nov 13, 2026, 1:30 PM CST
Gongwin Biopharm Holdings Market Cap
Gongwin Biopharm Holdings has a market cap or net worth of 16.59 billion as of November 13, 2026. It is the 14,280th most valuable company in the world and the 465th biggest in Taiwan. Its market cap has increased by 56.63% in one year.
Market Cap
16.59B
Enterprise Value
15.10B
Revenue
41.83M
Global Rank
Country Rank
#465 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since February 8, 2017, Gongwin Biopharm Holdings's market cap has increased from 8.87B to 16.59B, an increase of 87.15%. That is a compound annual growth rate of 6.63%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 16.59B | 57.17% |
| Dec 31, 2025 | 10.56B | -26.53% |
| Dec 31, 2024 | 14.37B | -31.28% |
| Dec 29, 2023 | 20.91B | -42.13% |
| Dec 30, 2022 | 36.13B | 16.16% |
| Dec 30, 2021 | 31.10B | 17.15% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Feb 8, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Oneness Biotech | 21.89B |
| Sunmax Biotechnology | 21.13B |
| Steminent Biotherapeutics | 19.06B |
| TaiMed Biologics | 16.94B |
| EirGenix | 16.13B |
| CHO Pharma | 16.11B |
| Medigen Vaccine Biologics | 15.39B |
| Ever Supreme Bio Technology | 14.66B |